Lincoln Pharmaceuticals Ltd.
Snapshot View

288.75 +5.50 ▲1.9%

27 June 2022, 04:01:00 PM
Volume: 16,320

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lincolnpharma.com
Market Cap 574.05 Cr.
Enterprise Value(EV) 559.20 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 34.63 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 8.34 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 216.12 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.34 Calculated using Price: 288.75
Dividend Yield 0.52 Period Ending 2021-03
No. of Shares Subscribed 2.00 Cr. 20,029,728 Shares
FaceValue 10
Company Profile
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.94%
1 Week
+4.20%
1 Month
+5.71%
3 Month
-10.73%
6 Month
-18.21%
1 Year
-8.74%
2 Year
+67.78%
5 Year
+62.86%
10 Year
+1008.45%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 11.21 10.83 14.32 19.49 17.29 16.63 19.75 17.67 18.09
Return on Capital Employed (%) 12.21 11.48 15.91 21.18 18.51 19.05 22.50 22.30 24.58
Return on Assets (%) 4.25 4.10 5.77 8.87 9.40 10.09 12.80 12.33 13.37

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 89 99 111 141 192 224 269 313 375 433
Non Curr. Liab. 25 26 33 34 32 25 28 43 26 11
Curr. Liab. 118 131 114 100 99 113 100 80 92 90
Minority Int. 4 4 3 0 0 0 0 0 0
Equity & Liab. 237 260 262 275 324 363 399 437 494 534
Non Curr. Assets 114 111 81 128 134 136 159 174 169 182
Curr. Assets 123 149 181 147 190 227 239 263 325 353
Misc. Exp. not W/O
Total Assets 237 260 262 275 324 363 399 437 494 534

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 195 210 266 400 360 361 366 386 424 472
Other Income 6 2 7 7 3 5 6 11 6 10
Total Income 201 213 273 408 363 366 372 398 430 482
Total Expenditure -179 -190 -240 -360 -314 -308 -299 -321 -337 -377
PBIDT 22 23 33 48 50 58 73 77 93 105
Interest -8 -7 -8 -10 -7 -5 -4 -2 -2 -1
Depreciation -3 -4 -5 -5 -6 -6 -7 -7 -8 -8
Taxation -2 -2 -5 -9 -9 -12 -13 -16 -21 -27
Exceptional Items
PAT 10 10 15 24 28 35 49 51 62 69
Minority Interest 0 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 10 11 15 24 28 35 49 51 62 69
Adjusted EPS 6 7 9 15 14 17 24 26 31 35

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 12 -16 5 25 45 25 27 53 75 69
Cash Fr. Inv. -27 -16 1 7 -42 -25 -12 -18 -31 -64
Cash Fr. Finan. 16 29 -11 -32 -3 0 -11 -36 -38 -6
Net Change 1 -3 -4 -1 0 0 3 -1 7 -1
Cash & Cash Eqvt 12 9 5 4 3 3 7 5 12 11

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 32.36 32.36 32.41 33.41 37.26 37.78 40.28 42.08 42.05
Public 67.64 67.64 67.59 66.59 62.74 62.22 59.72 57.92 57.95
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 15 Jun 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashish Rajanibhai Patel & PACs
Wed, 15 Jun 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs
Fri, 10 Jun 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Munjal Mahendrabhai Patel & PACs

Technical Scans View Details

Mon, 27 Jun 2022
Higher Trade Quantity Higher Trade Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 3 Months High Decrease 3 Months

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Lincoln Pharmaceuticals Ltd.

Can I Buy Lincoln Pharma Shares now?

What is the Share Price of Lincoln Pharma?

What is the Relative Strength Index (RSI) Value of Lincoln Pharma?

What is the Market Capital (MCAP) of Lincoln Pharma?

What are the key metrics to analyse Lincoln Pharma?

What is the Price Performance of Lincoln Pharma?